These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14652678)

  • 1. Heat shock proteins (HSP) for immunotherapy of rheumatoid arthritis (RA).
    Puga Yung GL; Le TD; Roord S; Prakken B; Albani S
    Inflamm Res; 2003 Nov; 52(11):443-51. PubMed ID: 14652678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis.
    Massa M; Passalia M; Manzoni SM; Campanelli R; Ciardelli L; Yung GP; Kamphuis S; Pistorio A; Meli V; Sette A; Prakken B; Martini A; Albani S
    Arthritis Rheum; 2007 May; 56(5):1648-57. PubMed ID: 17469159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of rheumatoid arthritis: current and future].
    Bentin J
    Rev Med Brux; 1993 Jun; 14(6):175-81. PubMed ID: 8367633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock proteins can be targets of regulatory T cells for therapeutic intervention in rheumatoid arthritis.
    Van Herwijnen MJ; Van Der Zee R; Van Eden W; Broere F
    Int J Hyperthermia; 2013 Aug; 29(5):448-54. PubMed ID: 23863094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe rheumatoid arthritis.
    Lorenzen I
    Ann Clin Res; 1983 Apr; 15(2):80-7. PubMed ID: 6349514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases.
    Van Eden W; Wick G; Albani S; Cohen I
    Ann N Y Acad Sci; 2007 Oct; 1113():217-37. PubMed ID: 17584980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-DR-binding Hsp60 self epitopes induce an interleukin-10-mediated immune response in rheumatoid arthritis.
    de Jong H; Lafeber FF; de Jager W; Haverkamp MH; Kuis W; Bijlsma JW; Prakken BJ; Albani S
    Arthritis Rheum; 2009 Jul; 60(7):1966-76. PubMed ID: 19565483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in heat shock protein-based cancer vaccines.
    Wang HH; Mao CY; Teng LS; Cao J
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):22-7. PubMed ID: 16481277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro effects of Mycobacterium bovis BCG-lysate and its derived heat shock proteins on cytokines secretion by blood mononuclear cells of rheumatoid arthritis patients in comparison with healthy controls.
    Sheikhi A; Nazarian M; Khadem-Al-Melleh A; Nasab NM; Esmaeilzadeh A; Yahaghi N; Sheikhi R
    Int Immunopharmacol; 2008 Jun; 8(6):887-92. PubMed ID: 18442794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis.
    Dugina JL; Petrov VI; Babayeva AR; Martyushev-Poklad AV; Tcherevkova EV; Epstein OI; Sergeeva SA
    Int J Tissue React; 2005; 27(1):15-21. PubMed ID: 15847101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of rheumatoid arthritis-related antigen RA-A47 (HSP47/colligin-2) in chondrocytic cell lines induces apoptosis and cell-surface expression of RA-A47 in association with CD9.
    Hattori T; von der Mark K; Kawaki H; Yutani Y; Kubota S; Nakanishi T; Eberspaecher H; de Crombrugghe B; Takigawa M
    J Cell Physiol; 2005 Jan; 202(1):191-204. PubMed ID: 15389525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heat shock proteins in rheumatoid arthritis: friend or foe?].
    Tukaj S; Lipińska B
    Postepy Hig Med Dosw (Online); 2011 Jun; 65():427-36. PubMed ID: 21734327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of rheumatoid arthritis: past, present and future.
    Sivakumar B; Paleolog E
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):169-76. PubMed ID: 15782541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness and the limitations of animal models in identifying targets for therapy in arthritis.
    Wooley PH
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):47-58. PubMed ID: 15123037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein vaccines: from bench to bedside.
    Binder RJ
    Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in molecular therapeutic approaches for rheumatoid arthritis.
    Woods A; Hobson P; Klavinskis LS
    Curr Opin Mol Ther; 2004 Aug; 6(4):395-402. PubMed ID: 15468598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of rheumatoid arthritis.
    Rindfleisch JA; Muller D
    Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat-shock proteins as drugs: potential applications in cancer, infections, and autoimmune and atopic diseases.
    Holzer AM; Martiniuk F; Levis WR
    J Drugs Dermatol; 2007 Apr; 6(4):393-9. PubMed ID: 17668536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.